Nimodipine lipid nano particle compositions, and its prepn. method
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHENYANG PHARMA UNIVERSITY
- Publication Date
- 2003-05-21
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
Technical field:
[0001] The invention relates to the technical field of medicine, in particular to a nimodipine lipid nanoparticle composition and a preparation method thereof. Background technique:
[0002] Nimodipine is a calcium channel blocker, which can dilate blood vessels and prevent cerebral ischemic damage. It is an ideal drug for patients with cerebrovascular diseases. No obvious adverse reactions (Li Zhaoren Nimodipine New Drug and Clinical 1987, 6(2): 12-124). It has the following characteristics: (1) Selective expansion of cerebral blood vessels: (2) Increase cerebral blood flow without 'blood stealing' phenomenon: (3) Increase cerebral blood circulation without increasing cerebral metabolism: (4) Anti-platelet aggregation. It is clinically used to treat subarachnoid hemorrhage, migraine, stroke, cerebrovascular insufficiency, sudden deafness, vestibular nystagmus, etc. In view of the above-mentioned characteristics, there are many dosage forms of nimodipine d...